Company Egyptian International Pharmaceutical Industries Company

PHAR

EGS38081C013

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Egyptian International Pharmaceutical Industries Company

Chiffre d''affaires - Rate of surprise

Sector Generic Pharmaceuticals

EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
35.97 ^EGP	+2.77%		-13.97%	-1.45%

Mar. 01	Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 05	Egyptian International Pharmaceutical Industries Company(CASE:PHAR) added to EGX 30 Index	CI

Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) specializes in manufacturing and marketing pharmaceutical products. The products include primarily antibiotics, vitamins, anesthetics and analgesics, drugs for eye care, treatment of rheumatism, gout, gastrointestinal, dermatological and cardiovascular diseases, and are administered as capsules, gels and effervescent tablets.

EGP in Million	2022	Weight	2023	Weight	Delta
Antibiotics, Lyophilized Products and Spansule Capsules 100.0 %	3,955	100.0 %	5,232	100.0 %	+32.27%

EGP in Million	2022	Weight	2023	Weight	Delta
Egypt 100.0 %	3,955	100.0 %	5,232	100.0 %	+32.27%

Managers	Title	Age	Since
Ahmed Said Mohammed Kilany El-Bucheiry CEO	Chief Executive Officer	-	-
Abdel Rahim Gharib Mohammed IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
Ahmed Said Mohammed Kilany El-Bucheiry CEO	Chief Executive Officer	-	-
Maher Mohammad Ali Al-Domiaty BRD	Director/Board Member	-	-
Fattouh Mohammad Salame Diab BRD	Director/Board Member	-	-
Ahmed Ali Layla BRD	Director/Board Member	-	-
Fathi Ibrahim Abdullah Ibrahim BRD	Director/Board Member	-	-
Adel Hassan Abdul Latif Adawy BRD	Director/Board Member	-	20-01-15
Mufid Mahmoud Shehab BRD	Director/Board Member	-	-
Hussain Mahmoud Hussain Khairy BRD	Director/Board Member	-	-
Madiha Mahmoud Khitab Abdullah BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	148,755,750	68,004,438 ( 45.72 %)	0	45.72 %

Name	Equities	%	Valuation
Arab Company for Drug Industries & Medical Appliances 50.01 %	74,387,504	50.01 %	72 M £
Sanlam Investment Management (Pty) Ltd. 0.4921 %	731,960	0.4921 %	710 338 £
Investec Asset Management Ltd. 0.3881 %	577,284	0.3881 %	560 231 £
AllianceBernstein Ltd. 0.3419 %	508,586	0.3419 %	493 562 £
Concord International Investments LP 0.3407 %	506,764	0.3407 %	491 794 £
Tundra Fonder AB 0.2192 %	326,054	0.2192 %	316 422 £
Trustus Capital Management BV 0.1979 %	294,414	0.1979 %	285 717 £
Mazi Asset Management (Pty) Ltd. 0.1312 %	195,241	0.1312 %	189 474 £
EFG-Hermes Asset Management SAE 0.0439 %	65,317	0.0439 %	63 388 £
Union Investment Privatfonds GmbH 0.0382 %	56,880	0.0382 %	55 200 £

Egyptian International Pharmaceutical Industries Co.

1st Industrial Zone B1

44629, Tenth of Ramadan City

http://www.eipico.com.eg

address Egyptian International Pharmaceutical Industries Company(PHAR)

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

35.97 EGP

Average target price

75.3 EGP

Spread / Average Target

+109.34%

Consensus

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY	-1.45%	112M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.98%	43.67B
OTSUKA HOLDINGS CO., LTD.	+20.67%	22.51B
SANDOZ GROUP AG	+14.56%	14.6B
CIPLA LIMITED	+14.32%	13.74B
ZYDUS LIFESCIENCES LIMITED	+44.72%	11.91B
ONO PHARMACEUTICAL CO., LTD.	-8.37%	7.04B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+11.90%	5.42B

Generic Pharmaceuticals